Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits In the article that accompanies this ...
Monoaminergic drugs are considered first-line treatment for major depressive disorder (MDD) but can take eight weeks or longer to achieve a response (defined as ≥50% symptom improvement) [1]. Symptom ...
Professor Yeonhee Park of the Department of Statistics at Sungkyunkwan University has developed a novel statistical framework — MARGO (Machine Learning-Assisted Adaptive Randomization for Group ...
Metastatic castration-resistant prostate cancer (mCRPC) is a genetically and clinically heterogeneous disease that can be treated with different classes of systemic agents, such as androgen receptor ...
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes Adequately prioritizing the numerous therapies and ...